Skip to main content

Table 2 Patient characteristics, injected 90 Y activity, and follow-up chest imaging

From: Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization

 

Valuesa

Gender

 

 Male

24

 Female

6

Ethnicity

 

 Chinese

20

 Indonesian

5

 Myanmar

4

 Others

1

Liver malignancy

 

 Hepatocellular carcinoma

25

 Metastatic colon cancer

4

 Cholangiocarcinoma

1

Age (years)b

 

 62.5 ± 11.2; 63.5

58.5 to 66.5; 28 to 80c

Injected 90Y activity (GBq)b

 

 1.65 ± 0.78; 1.44

1.37 to 1.93; 0.50 to 3.62c

Time from pre-RE diagnostic CT chest to 99mTc MAA SPECT/CT (weeks)b

 

 10.4 ± 21.8; 1.9

2.6 to 18.2; 0.3 to 105.3c

Time to follow-up chest imaging (months)b

 

 4.9 ± 3.4; 4.4

3.7 to 6.1; 1.2 to 17.5c

Follow-up chest imaging modality

 

 Diagnostic CT chest

25

 Chest X-ray

5

  1. aValues are expressed as n unless otherwise specified; bmean ± SD; median values; c95% CI; range values.